Advertisement

Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

Inhalable insulin: a losing battle?

The idea of delivering insulin via inhaler, rather than by injection, has been around for some time. However, the marketplace has proven surprisingly resistant – Pfizer dropped Exubera shortly after its launch, and recently Sanofi followed suit after its Afrezza saw disappointing sales. Why has this form of drug delivery failed to live up to its hype, and what lies ahead? Abi Millar finds out.

Download our 2018 Technology, Media & Telecoms Predictions worth over $5,000 for free

Close
Close
Close

Go Top